Overview
- Editors:
-
-
David C. Hess
-
Department of Neurology, Georgia Regents University, Augusta, USA
- Covers basic stem cell biology and principles of cell therapy
- Includes expertise on key topics like pros and cons of the use of conditioned media instead of cells, methods to enhance the potency of cells in host tissue and the in vivo tracking of cells/stem cells in the brain
- Reaches into the corporate sector with coverage of cell therapy from the perspective of biotech and "big Pharma" companies
- Includes supplementary material: sn.pub/extras
Access this book
Other ways to access
Table of contents (18 chapters)
-
-
-
-
-
- Yukiko Kasahara, Tomohiro Matsuyama, Akihiko Taguchi
Pages 37-46
-
-
- Vikram Jadhav, Pallab Bhattacharya, Dileep R. Yavagal
Pages 65-89
-
- Nathan C. Manley, Ricardo L. Azevedo-Pereira, Tonya M. Bliss, Gary K. Steinberg
Pages 91-109
-
- Keith W. Muir, John D. Sinden
Pages 111-128
-
- David C. Hess, Nasir Fakhri, Franklin D. West
Pages 129-146
-
- Vivian W. Lau, Simon R. Platt, Steven L. Stice, Franklin D. West
Pages 147-172
-
- David C. Hess, Md Nasrul Hoda
Pages 173-186
-
- Bhagelu R. Achyut, Ali S. Arbab
Pages 187-212
-
- Pouria Moshayedi, S. Thomas Carmichael
Pages 213-245
-
- Brian H. Johnstone, Keith L. March
Pages 247-265
-
- George Paul Liao, Charles S. Cox Jr
Pages 267-306
-
-
- Masahiro Tsuji, Michael V. Johnston
Pages 321-349
-
-
Back Matter
Pages 365-369
About this book
Cell Therapy for Brain Injury is a thorough examination of using state-of-the-art cell therapy in the treatment of strokes and other traumatic brain injuries. This invaluable book covers this niche topic in depth from basic stem cell biology and principles of cell therapy through proposed mechanisms of action of cell therapy in stroke, pre-clinical data in stroke models, ongoing clinical trials, imaging and tracking of cells with MRI, neural stem cells in stroke and the "big pharma" perspective of cell therapy. Each chapter is written by well-known leaders in each field, thus providing a wealth of expertise. The breadth of this book makes it essential reading for neuroscientists, stem cell biologists, researchers or clinical trialists at pharmaceutical or biotechnology companies. It also serves as a thorough introduction for graduate students or post-doctoral fellows who hope to work in these fields.
Editors and Affiliations
-
Department of Neurology, Georgia Regents University, Augusta, USA
David C. Hess
About the editor
Dr. David C. Hess, MD is currently Chairman and Professor, Department of Neurology, Joint Appointment, Institute of Molecular Medicine and Genetics and Joint Appointment, College of Graduate Studies at Georgia Regents University. He completed his MD at University of Maryland Medical College of Georgia in Baltimore and an internship and residency in Internal Medicine at Allegheny General Hospital in Pittsburgh, before completing an additional residency in Neurology at Georgia Health Sciences University in Augusta. Dr. Hess has authored or co-authored more than 150 papers. This book reflects the intersection between Dr. Hess' clinical interest in stroke and his research interest in stem cells.
